i Summary: A radioassay for the measurement of cortisol binding capacity in human serum was developed and the results validated by radioimmuiioassay of serum corticosteroid binding globulin. The mini-scale method is simple, reliable and rapid, and avoids Separation of partitioned phases. The linear correlation between the free cortisol index and free cortisol concentration äs calculated by the two methods utilizing serum samples with normal and abnormal protein concentrations was r = 0.962 (n = 114, p < 0.001) and the regression equation was y = 3.51 6 -2.632. The teehnique requires no preparation of reagents, and the assay can be performed in 45 minutes using 0.05 ml of serum or plasma.
_
In recent years, assays of salivary cortisol have been introduction , . * v . t 1<t x A ã dvocated äs a reliable alternative test for assessing Corticosteroid binding globulin (CBG; synonym adrenal Status, since direct techniques for the meatranscortin) binds Cortisol, and to a lesser extent some surement of unbound "free" cortisol in plasma are other sterpids, with relatively high affinity and low not available (3) . For serum samples, the most comcapacity. The physicochemical characteristics and mon methods so far described involve the combined clinical relevence of this protein have been compre-estimation of total plasma cortisol and its free frachensively reviewed elsewhere (l, 2). Cortisol circulates tion estimated by one of the following techniques: in the human blood stream in bound (about 75% of binding eapacity by equilibrium dialysis (4), ultrafiltotal cortisol tightly to corticosteroid binding globu-tration (5) , steady state gel filtration (6) or dextran lin and 10% loosely to albumin) and unbound frac-coated charcoal (7); other methods rely on the meations. Measurement of the latter in plasma is consid-surement of total cortisol and direct estimation of ered to be clinically more appropriate, since it reflects corticosteroid binding globulin by immunochemical the physiologically active form of the circulating cor-or radioimmunoassay (RIA) techniques (8, 9) . The tisol, and provides reliable Information, especially in major disadvantages of these methods include cumcases of altered corticosteroid binding globulin levels. bersome procedures, preparation of special reagents, Measurement of the unbound fraction is therefore unsuitability for automation, relatively large sample expected to become a frequently ordered test.
volumes or high cost.
We describe the development of a reliable, inexpensive and basically versatile technique for the measurement of patient plasma/serum binding eapacity for cortisol, which can be used in conjunction with the total cortisol level to estimate the free cortisol.
Subjects, Materials and Equipment

Subjects
Morning blood samples (10 ml) were obtained during fasting from 13 male and 18 female volunteers (not using oral contraceptives), 22 samples from 11 patients before and 12 hours after a single oral dose ( Phosphate buffer, 0.1 mol/I pH 8.0, was used throughout unless otherwise stated. Toluene containing 4 g/l 2,5-diphenyloxazole (PPO) and 0.04 g/l l,4-bis2-(4-methyl-5-phenyloxazole) benzene (DM-POPOP) was used äs a scintillant.
Equipment
Beta counting was performed with an LKB Rack Beta liquid scintillation counter model 1217 (Bromma, Sweden).
Quench was determined by the channels ratio rnethod, using an external set of quenched Standards consisting of 7 ampoules containing different quantities of quenching agent (carbon tetrachloride) and identical amounts of radioactivity (cat. no. QCR 50, Amersham International). Using the quench correction, counts were converted to disintegrations per minute.
Assays were carried out in 15 55 mm disposable plastic scintillation mini vials obtained from Wheaton Scientific, N.J. 08332, USA.
Methods and Results
Preparation of corticosteroid binding bulin Standards lo-
A pool of late pregnancy serum was obtained from women at over 28 weeks of gestation. Six dilutions were prepared in a pool of male serum which had been preheated at 60 °C for 2 hours. The corticosteroid binding globulin concentrations of these Standards were estimated by a modification of the Rosner method (10) where the binding protein is saturated with tritiated cortisol then precipitated with ammonium sulphate, and the mass of bound cortisol is detennined from the known speciflc activity of the added steroid. The Standards (with an assigned value of 35, 70, 150, 300, 700, and 1500 nmol/1) were aliquoted, and stored at -20 °C until used.
Principle of the method A fixed quantity of buffered 3 H-labelled cortisol is added to all samples and Standards. After equilibrium is attained, a fixed volume of toluene^based scintillation liquid is added, foliowed by short vortex mixing and the radioactivity estirnated JIJL a liquid scintillation counter at 4 °C.
The unbound cortisol immediately becomes partitioned into the organic solvent while protein-bound cortisol remains within the aqueous phase. The aqueous fraction makes no contribution to the photon yield of the scintillation System. Hencej a direct relationship exists between the amöunt of 3 HU labelled cortisol bound to plasma proteins (mairily corticosteroid binding globulin) and the decrease of total radioactivity. This priiiciple is supported by the following facts:
1. The observed quenching process is not asspciated with a concomitant shift in the 
Optimization of assay conditions
Scintillant volume
Three concentrations of 3 H-labelled cortisol with various scintillant volumes ranging ffom 0.5 to 3.5 rnl were counted. A plateau was reached at aboüt 2.5 inl of scintillant ( fig. 3) , indicäting no significant gains in counting efficiency if the volume of the scintillant was further increased. This volume was therefore used in all subsequent studies.
Effect of pH and incubation time
Using pregnancy or normal serum pools, 0.2 ml pf buffered 3 H-labeled cortisol (660 Bq) was ineubated at 37 °C with 0.05 ml of serum, foliowed by additiön of 2.5 ml of scintillant in one set, buffers of various pH ranging from 4 to 10 were used, while in the second set, assay tubes were incubated for various periods of time ranging from 0 to 120 min. A pH of 8.0 and an incubation time of 30 minutes were found to be optimal äs shown in figures 4 and 5 respectively. Dissociation rate of binding'prptein-cörti-sol complex Using the optimized conditions described above, a Standard curve was constructed, aiid serial counting of radiöactivity was perfonned immediately and after 100 minute intervals. The fraction of decrease in quenching was found to be 0.045 per hour at the lowest end and 0.072 per hour at the highest end of the Standard curve. However, these rates were gradually reduced to less than 0.01 per hour after the first five hours. Thus, the effect öf such dissociation was deemed relevant only for large routine assays, where under these circumstances either the Standard curve is counted repeatedly after every 30 samples or counting of the whole assay is delayed for 3 hours after toluene additiön.
Haemolysis
Heparinized erythrocytes were washed with saline and sübjected to 3 cycles of freezing and thawing. The haemoglobin epntent of the haemolysate was determined and incremental amounts of it were added to 3 serum samples which were assayed by the present method. Haemoglobin up to 6.5 g/l did not appear to interfere with the assay.
Precision
The within-batch coefficient of Variation, assessed by 10 simultaneous analyses of samples with low, normal and high concentration of corticosteroid binding globulin were 8.9, 5.2, and 6.8% respectively. The between-batch coefficient of Variation, assessed by analysis of a normal sample in 5 consecutive assays, was 8.2%.
Final assay protocol
The assay is carried out in mini vials. Reagents are added in duplicate s follows:
0.05 ml of Standard or patient serum; 0.2 ml of 
Corticosteroid binding globulin by radioiminunoassay
Serum concentrations of corticosteroid binding globulin were measured by a commercial radioimmunoassay kit and the free cortisol concentrations were estimated according to the man facturer's instruc-tions. According to the marmfacturer, the validity of such estimations has been proved by comparison with free cortisol levels determined by Ultrafiltration (n = 60, r = 0.9444, y = 0.892 χ + 1.38 nmol/1).
Clinical observations in normal and patient samples
As expected, no statistically significant differences were detected in the values for binding capacity or actual corticosteroid binding globulin levels between apparently normal males and females. Furthermore, pregnancy samples exhibited higher levels for both Parameters s shown in table l.
The serum binding capacity was inversely related to changes in cortisol concentrations, e. g. the decrease of cortisol in the dexamethazone suppression test, the rise during the short synacthen test, and the decline in midnight levels ( fig. 7) .
The relationship between the estimates of free cortisol concentration (obtained from total cortisol and corticosteroid binding globulin concentration) and free cortisol index (obtained from total cortisol and values of binding capacity), shown in figure 8 , gave a correlation coefficient of r = 0.962 and a linear regression equation y = 3.516 χ -2.632.
These results indicate that the method we have developed has quite acceptable limits of specificity and sensitivity for clinical application.
Discussion
It is well established that serum cortisol is in a state of dynamic equilibrium with both corticosteroid binding globulin and albumin, and that these two proteins form quantitatively significant dissociable complexes with some other steroid hormones (e. g., progesterone
Tab. l. Estimated values (mean ± l SD) for total cortisol, cortisol binding capacity,. corticosteroid binding protein by RIA, free cortisol concentration, and free cortisol index in sera of apparently normal males, females and pregnant women. The principai advantages of the present method are: convenience, low cost, long shelf life of reagents, and adeqüate specificity and accuracy for routine clinical use. The assay requires no conyeiitional Separation
Step. Automation or predilution of samples are theref ore possible, and the assäy can be performed in a relatively short time. Furthermore, the total analyti*· cal procedure, from mixiiig the reactants to the actual counting, is performed in one mini vial, with a consequent reduction in cost.
In comparison with other methods, our protocol described here yields values for serum binding capacity for cortisol (230 mmol/1) which are similar to those reported by öthers (1 In conclusion, we have presented a routine laboratory method for measuring serum protein binding for cortisol that can be applied, in conjunction with the concentration of serum total cortisol, to provide valuable Information relevant to the diagnosis and/or therapeutic choices in relation to adrenocortical function.
